September Research Roundup: What We’re Reading

In our newest monthly roundup of health policy research, CHIR’s Rachel Swindle reviews studies on consumer knowledge of marketplace options, the consequences of allowing the American Rescue Plan’s marketplace subsidies to expire, and downstream impacts of cost sharing trends. 

Limited Plans with Minimal Coverage Are Being Sold as Primary Coverage, Leaving Consumers at Risk

People shopping for health insurance online are often directed to websites using misleading or deceptive practices to steer them to products that are not compliant with the Affordable Care Act, such as fixed indemnity policies. In a new post for the Commonwealth Fund’s To the Point blog, CHIR’s Dania Palanker and Kevin Lucia discuss the marketing of limited plans as a primary form of coverage and the risks these products pose to consumers. 

Final Round of Rulemaking for 2022 Affordable Care Act Marketplaces: Implications for States

The Biden administration continues to put its stamp on the Affordable Care Act marketplaces with new rules to expand enrollment and consumer assistance, increase plan oversight, and reverse several Trump administration policies. In her latest post for the State Health & Value Strategies program, CHIR’s Sabrina Corlette highlights the issues of particular importance to state marketplaces and departments of insurance.

The No Surprises Act Proposed Rule on Air Ambulances and Enforcement: Implications for States

This month the Biden administration released a second rule implementing the No Surprises Act, the new federal law banning balance bills in certain care settings and circumstances starting in 2022. In an Expert Perspective for the State Health & Value Strategies project, CHIR experts JoAnn Volk and Sabrina Corlette review provisions of the proposed rules of particular import to state-based marketplaces and state insurance regulators.

Building a Better Transparency Mousetrap: Recommendations to Optimize Hospital and Health Plan Price Disclosures

Amidst high and rising health care costs, recent federal regulations require hospitals and health plans to publicly post their prices. Such data can be useful for those seeking to control costs and improve affordability, but lack of compliance with the new requirements and data accessibility have made analysis difficult. To gain insights into the potential for this data and generate ideas for how to optimize the information to help reduce health system costs, CHIR convened a meeting of health care researchers, purchasers, and insurance regulators from around the country.

Public Input on How to Design a Federal Public Option

Congressional leaders requested input from the public on how to design a federal public health insurance option. CHIR’s Christine Monahan compiled and reviewed dozens of publicly available responses and shares key takeaways, as well as links so you can take a closer look.

August Research Roundup: What We’re Reading

For the latest monthly roundup of health policy research, CHIR’s Rachel Swindle takes a look at studies published in August on the how the uninsured rate has held steady during the COVID-19 pandemic and expiration of cost-sharing waivers for COVID-19 treatment.

Federal Committee Recommends Airline Deregulation Act Changes to Avoid Conflicts with No Surprises Act

Air ambulances are one of the largest sources of surprise medical bills. While the No Surprises Act would protect patients from balance bills from out-of-network air ambulance providers, another federal law – the Airline Deregulation Act – could raise questions about states’ authority to enforce these consumer protections. CHIR’s Madeline O’Brien and Jack Hoadley describe a federal advisory committee’s recommendations to resolve potential conflicts.

Stakeholder Perspectives on Round Three of CMS’s 2022 Notice of Benefit and Payment Parameters. Part 3: Consumer Advocates

The Biden administration has proposed several policy changes designed to boost enrollment in the Affordable Care Act marketplaces. In the third post of a 3-part blog series, JoAnn Volk and Nia Gooding review comments submitted by several consumer and patient advocacy groups. Prior posts reviewed comments from health insurers and state marketplace and insurance officials.

Stakeholder Perspectives on Round Three of CMS’s 2022 Notice of Benefit and Payment Parameters. Part 2: Insurers

In the newly proposed 2022 “Notice of Benefit & Payment Parameters” the Biden Administration is reversing course on a number of policies that impact the ACA marketplaces. In the second of a three-part series, CHIR’s Megan Houston reviewed public comments from insurers about the proposed rule. Reviews of comments from consumer organizations will follow.

The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.